DEFEROXAMINE for Haematological malignancy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where DEFEROXAMINE was used for Haematological malignancy.
Most Reported Side Effects for DEFEROXAMINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Serum ferritin increased | 78 | 9.3% | 13 | 35 |
| Drug ineffective | 75 | 8.9% | 17 | 28 |
| Death | 71 | 8.5% | 71 | 17 |
| Diarrhoea | 55 | 6.6% | 6 | 36 |
| Vomiting | 47 | 5.6% | 7 | 37 |
| Malaise | 38 | 4.5% | 10 | 20 |
| Nausea | 36 | 4.3% | 5 | 18 |
| Abdominal pain | 35 | 4.2% | 6 | 21 |
| Haemoglobin decreased | 34 | 4.1% | 8 | 14 |
| Off label use | 34 | 4.1% | 9 | 15 |
| Pain | 33 | 3.9% | 2 | 16 |
| Pyrexia | 32 | 3.8% | 5 | 26 |
| Dyspnoea | 28 | 3.3% | 5 | 18 |
| Fatigue | 28 | 3.3% | 5 | 19 |
| Acute kidney injury | 26 | 3.1% | 6 | 19 |
Other Indications for DEFEROXAMINE
Product used for unknown indication (252)
Iron overload (167)
Thalassaemia (88)
Myelodysplastic syndrome (43)
Haemochromatosis (37)
Chelation therapy (35)
Thalassaemia beta (35)
Sickle cell anaemia (14)
Hyperferritinaemia (11)
Congenital aplastic anaemia (10)
Other Drugs Used for Haematological malignancy
RITUXIMAB (144)
CYCLOPHOSPHAMIDE (97)
FLUDARABINE (93)
BUSULFAN (80)
LENALIDOMIDE (71)
IBRUTINIB (62)
DOXORUBICIN (61)
BEVACIZUMAB (55)
GENOXAL INYECTABLE (49)
MYCOPHENOLATE (49)